Behcet's syndrome: A multidisciplinary approach to clinical care

QJM: An International Journal of Medicine

Volumn 92, Issue 12, 1999, Pages 727-740

  Whallett, A J ^a,d   Thurairajan, G ^b   Hamburger, J ^c   Palmer, R G ^a   Murray, P I ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c BIRMINGHAM DENTAL HOSPITAL   (United Kingdom)

^d SOLIHULL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; CYCLOSPORIN; GOLD; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISOLONE; SALAZOSULFAPYRIDINE; THALIDOMIDE; WARFARIN;

ADOLESCENT; ADULT; ARTICLE; BEHCET DISEASE; CELL DAMAGE; CLINICAL ARTICLE; DISEASE ACTIVITY; ENDOTHELIUM CELL; EYE DISEASE; FEMALE; GENITAL ULCER; HISTOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTIC INFILTRATION; MALE; MOUTH ULCER; NEUROLOGIC DISEASE; ONSET AGE; OPHTHALMOLOGY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOLOGY; THROMBOSIS; VASCULITIS; AGED; DISEASE COURSE; LONGITUDINAL STUDY; MIDDLE AGED; PATIENT CARE; SKIN DISEASE; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGED; BEHCET SYNDROME; DISEASE PROGRESSION; EYE DISEASES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; ORAL ULCER; PATIENT CARE TEAM; SKIN DISEASES; VASCULAR DISEASES;

EID: 0033250957     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/92.12.727     Document Type: Article

References (26)

1. Mason RM, Barnes CG. Behçet's syndrome with arthritis. Ann Rheum Dis 1969; 28:95-103.
2. Inaba G. Behçet's disease. In: Vinken PJ, Bruyn GW, Klawans HL eds. Handbook of Clinical Neurology. Amsterdam, Elsevier Science Publishers, 1989; 12:593-610.
3. Mizushima Y. Recent research into Behçet's disease in Japan. Int J Tissue React 1988; 10:59-65.
4. O'Duffy JD. Criteres proposes pour le diagnostique de la maladie de Behçet et notes therapeutique. Rev Med 1974; 36:2371-9.
5. Dilsen N, Konice M, Aral O. Our diagnostic criteria for Behçet's disease - an overview. In: Lehner T, Barnes CG, eds. Recent advances in Behçet's disease. London, Royal Society of Medicine Services International Congress and Symposium Series 1986; 103:177-80.
6. International Study Group for Behçet's Disease. Criteria for the diagnosis of Behçet's Disease. Lancet 1990; 335:1078-80.
7. Rigby AS, Chamberlain MA, Bhakta B. Behçet's disease. Bailliere's Clin Rheumatol 1995; 9:375-95.
8. Lehner T. Oral ulceration and Behçet's syndrome. Gut 1977; 18:491-511.
9. Axell T, Henricsson V. Association between recurrent aphthous ulcers and tobacco habits. Scand J Dental Res 1985; 93:239-42.
10. Davies PC, Fordham JN, Kirwan JR, Barnes CG, Dinning WJ. The pathergy test and Behçet's syndrome in Britain. Ann Rheum Dis 1984; 43:70-3.
11. Yazici H, Chamberlain MA, Tuzun Y, Yurkadul S, Muftuoglu AU. Comparative study of the pathergy reaction among Turkish and British patients with Behçet's disease. Ann Rheum Dis 1984; 43:74-5.
12. Friedman-Birnbaum R, Bergman R, Aizen E. Sensitivity and specicifity of pathergy test results in Israeli patients with Behçet's disease. Cutis 1990; 45:261-4.
13. Chamberlain MA. Behçet's syndrome in 32 patients in Yorkshire. Ann Rheum Dis 1977; 36:491-9.
14. Davies UM, Palmer RG, Denman AM. Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: a randomized double-blind trial. Br J Rheumatol 1988; 27:300-2.
15. O'Neill T, Righy AS, McHugh S, et al. Regional differences in clinical manifestation of Behçet's disease. In: Wechsler B, Godean P, eds. Behçet's Disease, Excerpta Medica International congress series 1037. Amsterdam, Elsevier Science, 1993:159-63.
16. Nakae K, Masaki F, Hashimoto T, Inaba G, Moshizuki M, Sakane T. Recent epidemiological features of Behçet's disease in Japan. In: Godean P, Wechsler B, eds. Behçet's Disease. Amsterdam, Elsevier Science, 1993.
17. Davatchi F, Shahram F, Akbarian M, Gharibdoost F, Nadji A, Chams C, Chams H, Jamshidi AR. Behçet's disease -Analysis of 3443 cases. APLAR J Rheum 1997; 1:2-5.
18. Dilsen N, Konice M, Aral O, Ocal L, Inanc M, Gul A. Risk factors for vital organ involvement in Behçet's disease. In: Godean P, Wechsler B, eds. Behçet's Disease. Amsterdam, Elsevier Science, 1993.
19. Dinning WJ. An overview of ocular manifestations. In: Lehner T, Barnes CG, eds. Recent advances in Behçet's disease, Royal Society of Medicine Services International Congress and Symposium Series 103. London, Royal Society of Medicine, 1986:227-33.
20. Sakamoto M, Akazawa K, Nishioka Y, Sanui H, Inomata H, Nose Y. Prognostic factors of vision in patients with Behcet disease. Ophthalmology 1995; 102:317-21.
21. Demiroglu H, Barista I, Dundar S. Risk factor assessment and prognosis of eye involvement in Behçet's disease in Turkey. Ophthalmology 1997; 104:701-5.
22. Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Yalcin B, Muftouglu A. Behçet's disease as seen in Turkey. Haematologica 1980; 65:381-3.
23. Masuda K, Urayama A, Kogure M. Double masked trial of cyclosporin in Behçet's disease. Lancet 1989; 1:1093-5.
24. Vitale AT, Rodriguez A, Foster CS. Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis. Ophthalmology 1996; 103:365-74.
25. Yazici H, Pazarli H, Barnes CG, Tuzun Y, Ozazgan Y, Silman A, Serdaroglu S, Oguz V, Yurkadul S, Lovatt GE, Yazici B, Somani S, Muftuoglu A. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 1990; 322:281-5.
26. Aktugla E, Altac M, Muftuoglu A, Ozyazgan Y, Pazarli H, Tuzun Y, Yalcin B, Yazici H, Yardakul S. A double-blind study of colchicine in Behçet's disease. Haematologica 1980; 65:399-402.